GLENMARK PHARMACEUTICALS INC., USA

549300P2PTIYYGIM8U12

The entity

Status: Active
LEI status: Issued and current
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: December 11, 2002

Address

Country: United States
Legal address: C/O CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE19808 WILMINGTONUnited States (US-DE)
Head office: 750 Corporate Drive07430 MahwahUnited States (US-NJ)

Identifier

LEI: 549300P2PTIYYGIM8U12
Registered: January 22, 2021 at 09:31 PM UTC
Last updated: March 11, 2026 at 03:23 PM UTC
Next renewal: March 11, 2027 at 03:23 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 3600881
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 3600881
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

Glenmark Holding SA
Direct parentSwitzerland506700E62GR12JRI9878
GLENMARK PHARMACEUTICALS LIMITED
Ultimate parentIndia335800WKECZXIIT9GK20

Machine access

REST: https://lei.online/v1/entities/549300P2PTIYYGIM8U12This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search